Cargando…
Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE
Studies have reported increased intestinal permeability in multiple sclerosis (MS) patients and its mouse model experimental autoimmune encephalomyelitis (EAE). However, the mechanisms driving increased intestinal permeability that in turn exacerbate neuroinflammation during EAE remain unclear. Here...
Autores principales: | Bianchimano, Paola, Iwanowski, Kacper, Smith, Emma M., Cantor, Adam, Leone, Paola, Bongers, Gerold, Gonzalez, Carlos G., Hongsup, Yoon, Elias, Joshua, Weiner, Howard L., Clemente, Jose C., Tankou, Stephanie K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616394/ https://www.ncbi.nlm.nih.gov/pubmed/37915599 http://dx.doi.org/10.1016/j.isci.2023.108143 |
Ejemplares similares
-
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis
por: Bianchimano, Paola, et al.
Publicado: (2022) -
Rethinking EAE pathogenesis
por: Van Epps, Heather L.
Publicado: (2005) -
PARing down EAE
por: Van Epps, Heather L.
Publicado: (2006) -
Optimisation of the preservation conditions for molecularly imprinted polymer nanoparticles specific for trypsin
por: Safaryan, Abeer H. M., et al.
Publicado: (2019) -
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
por: Menachery, Vineet D., et al.
Publicado: (2020)